Rezolute, Inc. (RZLT)
NASDAQ: RZLT · IEX Real-Time Price · USD
4.450
-0.070 (-1.55%)
Jul 22, 2024, 10:02 AM EDT - Market open
Rezolute Employees
Rezolute had 51 employees as of June 30, 2023. The number of employees increased by 9 or 21.43% compared to the previous year.
Employees
51
Change (1Y)
9
Growth (1Y)
21.43%
Revenue / Employee
n/a
Profits / Employee
-$1,141,392
Market Cap
237.40M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
2seventy bio | 274 |
NeuroPace | 171 |
Gossamer Bio | 135 |
Mersana Therapeutics | 123 |
Semler Scientific | 92 |
Design Therapeutics | 58 |
Cybin | 50 |
ESSA Pharma | 50 |
RZLT News
- 25 days ago - Rezolute Announces Exercise of Underwriters' Option to Purchase Additional Shares and Concurrent Private Placement - GlobeNewsWire
- 4 weeks ago - Rezolute Announces Closing of Public Offering with Approximately $60M in Gross Proceeds - GlobeNewsWire
- 5 weeks ago - Rezolute Announces Pricing of Public Offering of $60 Million of Common Stock and Pre-Funded Warrants - GlobeNewsWire
- 5 weeks ago - Rezolute Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire
- 7 weeks ago - Rezolute to Participate in the Jefferies Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Rezolute Reports Positive Topline Results from Phase 2 Proof of Concept Study of RZ402 in Patients with Diabetic Macular Edema (DME) - GlobeNewsWire
- 2 months ago - Rezolute Reports Third Quarter Fiscal 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 3 months ago - Phase 2 RIZE Study Sub-Analyses to be Presented at the 2024 Pediatric Endocrine Society Annual Meeting - GlobeNewsWire